Menu

• Ask a Health Expert about PANCREATIC CARCINOMA METASTATIC
• Post Your Side Effect related to PANCREATIC CARCINOMA METASTATIC
• PANCREATIC CARCINOMA METASTATIC and FDA Warnings
• PANCREATIC CARCINOMA METASTATIC in Patients Wiki
• Report PANCREATIC CARCINOMA METASTATIC in Drug Side Effect Survey

PANCREATIC CARCINOMA METASTATIC side effect

What is PANCREATIC CARCINOMA METASTATIC ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Byetta Side Effects Report #5655481-2
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Feb 28, 2008. Male patient, weighting 172.0 lb, was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, pancreatitis acute, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, AVANDIA, ASPIRIN, ALTACE, LIPITOR, TRICOR, ZETIA. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5659563-0
REMICADE problem was reported by a Health Professional from UNITED STATES on Feb 29, 2008. Male patient, weighting 200.0 lb, was diagnosed with rheumatoid arthritis, hypertension, lipids abnormal and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, ATENOLOL, CLONIDINE, DIAVAN, MAXZIDE, NIACIN. Patient recovered.

Remicade Side Effects Report #5661526-6
Physician from SPAIN reported REMICADE problem on Mar 03, 2008. Female patient, 50 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. During the same period patient was treated with IMUREL. Patient recovered.

Enbrel Side Effects Report #5661649-1
ENBREL problem was reported by a Consumer or non-health professional from SPAIN on Feb 28, 2008. Male patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . ENBREL dosage: unknown. Patient died.


Enbrel Side Effects Report #5640623-5
Health Professional from UNITED KINGDOM reported ENBREL problem on Feb 14, 2008. Male patient, 61 years of age, was diagnosed with psoriasis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, skin nodule, . ENBREL dosage: unknown. Patient died on 02/14/2008.

Remicade Side Effects Report #5600904-8
REMICADE problem was reported by a Physician from JAPAN on Jan 17, 2008. Female patient, weighting 114.6 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. Patient was hospitalized. Patient died on 04/16/2007.

Sirolimus Side Effects Report #5400123-4
Physician from UNITED STATES reported SIROLIMUS problem on July 19, 2007. Male patient, weighting 191.2 lb, was diagnosed with prophylaxis against transplant rejection, hyperlipidaemia, hypertension and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . SIROLIMUS dosage: unknown. During the same period patient was treated with ZOCOR, LANTUS, COZAAR, SEPTRA, NOVOLOG. Patient was hospitalized. Patient died on 07/16/2007.

Sirolimus Side Effects Report #5400123-4
SIROLIMUS problem was reported by a Physician from UNITED STATES on July 19, 2007. Male patient, weighting 191.2 lb, was diagnosed with prophylaxis against transplant rejection, hyperlipidaemia, hypertension and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . SIROLIMUS dosage: unknown. During the same period patient was treated with ZOCOR, LANTUS, COZAAR, SEPTRA, NOVOLOG. Patient was hospitalized. Patient died on 07/16/2007.

Remicade Side Effects Report #5738955-5
Health Professional from UNITED STATES reported REMICADE problem on May 06, 2008. Male patient, weighting 200.0 lb, was diagnosed with rheumatoid arthritis, hypertension, lipids abnormal and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, ATENOLOL, CLONIDINE, DIAVAN, MAXZIDE, NIACIN. Patient was hospitalized. Patient died on 03/01/2008.


Sirolimus Side Effects Report #5353596-X
SIROLIMUS problem was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, weighting 191.2 lb, was diagnosed with prophylaxis against transplant rejection, hyperlipidaemia, hypertension and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . SIROLIMUS dosage: unknown. During the same period patient was treated with ZOCOR, LANTUS, COZAAR, SEPTRA, NOVOLOG. Patient recovered.

Zocor Side Effects Report #5605765-9
Consumer or non-health professional from CANADA reported ZOCOR problem on Jan 16, 2008. Male patient, 60 years of age, was diagnosed with acute coronary syndrome and was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . ZOCOR dosage: 40 MG/DAILY PO. During the same period patient was treated with COVERSYL, ELAVIL, MONOCOR, NITRO, PLAVIX, PREVACID. Patient was hospitalized. Patient died.

Infliximab Side Effects Report #5520326-8
INFLIXIMAB problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Female patient, weighting 117.0 lb, was diagnosed with crohn's disease and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, pancreatic carcinoma metastatic, . INFLIXIMAB dosage: unknown. During the same period patient was treated with MESALAMINE, QUESTRAN. Patient died on 11/04/2007.

Calcium Side Effects Report #5469860-X
Physician from UNITED STATES reported CALCIUM WITH VITAMIN D problem on Sept 12, 2007. Female patient, 68 years of age, weighting 159.0 lb, was diagnosed with hypersensitivity, osteoporosis and was treated with CALCIUM WITH VITAMIN D. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pancreatic carcinoma metastatic, pulmonary embolism, . CALCIUM WITH VITAMIN D dosage: unknown. During the same period patient was treated with CALCIUM WITH VITAMIN D, ZYRTEC, ASPIRIN, SYNTHROID, EVISTA. Patient recovered.

Xeloda Side Effects Report #5416798-X
XELODA problem was reported by a Health Professional from UNITED STATES on Aug 08, 2007. Male patient, 64 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: fluid retention, pancreatic carcinoma metastatic, . XELODA dosage: unknown. Patient was hospitalized. Patient died on 07/11/2007.


Natalizumab Side Effects Report #5424465-1
Physician from GERMANY reported NATALIZUMAB problem on Aug 10, 2007. Male patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with CIPRALEX, MIRTAZAPINE. Patient recovered.

Byetta Side Effects Report #5293923-5
BYETTA problem was reported by a Physician from UNITED STATES on Mar 30, 2007. Female patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . BYETTA dosage: unknown. Patient died on 01/04/2007.

Erlotinib Side Effects Report #5301498-7
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 27, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pancreatic carcinoma metastatic, pulmonary embolism, . ERLOTINIB dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.

Byetta Side Effects Report #5259050-8
BYETTA problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . BYETTA dosage: unknown. Patient recovered.

Humira Side Effects Report #5276292-6
Physician from BELGIUM reported HUMIRA problem on Mar 19, 2007. Female patient, weighting 136.7 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, pancreatic carcinoma metastatic, . HUMIRA dosage: unknown. Patient was hospitalized. Patient recovered.


Tysabri Side Effects Report #5682167-0
TYSABRI problem was reported by a Consumer or non-health professional from GERMANY on Mar 13, 2008. Male patient, 55 years of age, weighting 152.1 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: helicobacter gastritis, metastases to liver, pancreatic carcinoma metastatic, weight decreased, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with CIPRALEX, MIRTAZAPINE. Patient died on 01/22/2008.

Xeloda Side Effects Report #5476845-6
Health Professional from UNITED STATES reported XELODA problem on Sept 24, 2007. Male patient, 42 years of age, weighting 257.1 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: oral mucosal blistering, palmar-plantar erythrodysaesthesia syndrome, pancreatic carcinoma metastatic, . XELODA dosage: unknown. Patient died on 07/27/2007.

Prograf Side Effects Report #5448472-8
PROGRAF problem was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, weighting 246.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma pancreas, hepatic neoplasm malignant, pancreatic carcinoma metastatic, . PROGRAF dosage: unknown. During the same period patient was treated with NORVASC, ACTIGALL, BACTRIM, METOPROLOL TARTRATE, ASPIRIN, DILAUDID. Patient died on 06/26/2006.

Revatio Side Effects Report #5428043-X
Physician from GERMANY reported REVATIO problem on Aug 21, 2007. Female patient, weighting 77.16 lb, was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: cardiac failure, diarrhoea, pancreatic carcinoma metastatic, . REVATIO dosage: DAILY DOSE:30MG. During the same period patient was treated with BOSENTAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5440538-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Aug 27, 2007. Male patient, 52 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant neoplasm progression, pancreatic carcinoma metastatic, . BEVACIZUMAB dosage: 10 MG/M2, DAYS 1+15/28DC. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATIVAN, CELEXA, LIDOCAINE MAALOX, DIPHENHYDRAMINE, REGLAN, SENNA. Patient died on 08/06/2007.

Prograf Side Effects Report #5272837-0
Physician from UNITED STATES reported PROGRAF problem on Mar 20, 2007. Male patient, weighting 246.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma pancreas, hepatic neoplasm malignant, pancreatic carcinoma metastatic, . PROGRAF dosage: unknown. During the same period patient was treated with NORVASC, ACTIGALL, BACTRIM, METOPROLOL TARTRATE, ACETYLSALICYLIC ACID SRT, DILAUDID, ULTRAM. Patient died on 06/26/2006.